London, 25 March 2025: Innovator and biosimilar drug approvals by the FDA have declined by 15.44%, from 149 in 2023 to 126 in 2024. Despite this downturn, the landscape of pharmaceutical innovation remains vibrant, particularly among smaller companies, which are making significan......
View Details

Related News

• A drug manufacturing facility operating without license busted in Kharkhoda (25-03-2025)

---

• Delhi HC allows Natco to make Roche's spinal muscular atrophy drug 'Risdiplam' in public interest (25-03-2025)

---

• Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)

---

• Supplement firm Bioventra warns of online fakes (25-03-2025)

---

• No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)

---

• Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)

---

• CDSCO asks MSME pharma firms to apply online for Schedule M extension (24-03-2025)

---

• Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)

---

• AI-driven device by PGI set to transform neuropathic pain diagnosis (24-03-2025)

---

• Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)

---